The Prescription Drug User Fee Act (PDUFA) for lofexidine is May 26; FDA actions on new drug applications often occur at near the PDUFA date.
The FDA is not obligated to follow the recommendations of its advisory committees.
REPORTING FROM AN FDA ADVISORY COMMITTEE MEETING